8:03 am Actavis confirms that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Dronedarone Hydrochloride Tablets 400 mg
View todays social media effects on ACT
View the latest stocks trending across Twitter. Click to view dashboard
See who Actavis is hiring next, click here to view
